Abstract: Provided are an anti-human CD3 antibody and the use thereof. Specifically, provided are an antibody specifically binding to human CD3 or an antigen binding fragment thereof, a multi-specific antigen binding molecule, an isolated nucleic acid molecule, a vector, a cell and an immune effector cell thereof, a method for preparing the antibody or the antigen binding fragment thereof, the multi-specific antigen binding molecule and the immune effector cell, a pharmaceutical composition, the pharmaceutical use and a method for treating diseases.

Abstract: Soyasaponin-related Kompetitive Allele Specific polymerase chain reaction (KASP) markers and an application thereof are provided in the present application, belonging to the technical field of molecular breeding. The KASP markers include one or two of S07_43139773G/T, and S07_43139033A/G; the S07_43139773G/T comprises a base of G/T at a position of 43139773 bp on chromosome 7 of a soybean genome, the S07_43139033A/G comprises a base of A/G at a position of 43139033 bp on the chromosome 7 of the soybean genome. The KASP markers are applied to improve soyasaponin germplasm breeding.

Abstract: Some embodiments provide a method for performing data traffic monitoring. The method processes a packet through a packet processing pipeline that includes multiple stages. At a filtering stage, the method tags the packet with a set of monitoring actions for subsequent stages to perform on the packet based on a determination that the packet matches a particular filter. For each stage of a set of packet processing stages subsequent to the filtering stage, the method (i) executes any monitoring actions specified for the stage to perform on the packet and (ii) sends the packet to a next stage in the packet processing pipeline.

Abstract: The technology is generally directed to a coordinated power throttling mechanism for a payload using power provided by a rack such that the rack power does not exceed a threshold amount for greater than a predetermined period of time. The coordinated power throttling mechanism includes the rack providing a power throttling signal to the payload and the payload executing the power throttling upon detection of the throttling signal. The payload may detect the throttling signal and, after a delay, execute the power throttling. The delay may ensure that all payloads within the rack have detected the power throttling signal.

Abstract: Provided herein, inter alia, are compositions of short chain fatty acid (SCFA)-producing microorganisms and methods of making and using the same to inhibit pathogenic bacterial populations in the gastrointestinal tracts of an animal and additionally promote improvement of one or more metrics in an animal, such as increased bodyweight gain, decreased feed conversion ratio (FCR), improved gut barrier integrity, reduced mortality, reduced pathogen infection, and reduced pathogen shedding in feces.

Abstract: A molecular marker significantly associated with vitamin E content in soybeans, a Kompetitive Allele-Specific polymerase chain reaction (KASP) primers combination and an application thereof are provided in the present disclosure, belonging to the field of molecular genetics and breeding. A nucleotide sequence of the molecular marker is shown in SEQ ID NO. 1, and there is an A/T mutation at the 21st base. The KASP primer set for detecting the molecular marker includes an upstream primer F1 with a nucleotide sequence as shown in SEQ ID NO. 2, an upstream primer F2 with a nucleotide sequence as shown in SEQ ID NO. 3 and a downstream primer r with a nucleotide sequence as shown in SEQ ID NO. 4. The KASP primers combination developed by the present disclosure accurately distinguish soybeans with high and low vitamin E content.

Abstract: A CD19 antibody and an application thereof, an antibody or antigen binding fragment specifically binding to human CD19, a multi-characteristic antigen binding molecule, a chimeric antigen receptor, an immune effector cell, a nucleic acid molecule, a vector, a cell, a preparation method, a pharmaceutical composition, a pharmaceutical use, and a disease treatment method. The present invention has great significance for the development of drugs for treating CD19-related diseases.

Abstract: Provided herein, inter alia, are compositions comprising one or more biologically pure strains of bacteria as well as methods of making and using the same to treat and/or prevent one or more obesity related disorders in a subject in need thereof.

Abstract: Some embodiments provide a method for monitoring a multi-tenant network management system deployed in a cloud to manage groups of datacenters. The network management system includes multiple groups of service instances. For each respective group of service instances deployed in the cloud to manage a respective datacenter group, the method deploys a metrics collection agent within each service instance of the group of service instances to collect metrics from services of the service instance and provide the collected metrics to a metric monitoring service instance of the group of service instances. For each respective group of service instances, the method deploys a metrics collection manager within the metric monitoring service instance of the group of service instances. The metrics collection manager is for configuring each of the metrics collection agents deployed within the service instances of the group of service instances.

Abstract: Some embodiments provide a method for monitoring a multi-tenant network management system deployed in a public cloud to manage groups of datacenters. Each respective datacenter group includes one or more datacenters of a respective tenant that defines the datacenter group. For each datacenter group of a set of datacenter groups managed by the multi-network management system, the method deploys a set of network management service instances in the cloud specified by the tenant for the datacenter group. Each of the network management service instances provides a specified service to the datacenters of the datacenter group. For each datacenter group, the method deploys a metric monitoring service instance in the cloud for the datacenter group. The metric monitoring service instance is for collecting and analyzing metrics from services belonging to each of the network management service instances deployed for the datacenter group.

Abstract: Some embodiments of the invention provide a method for performing dynamic packet tracing in a network that includes a network controller and multiple host computers, each host computer including a set of packet processing stages for processing packet flows in the network. The method is performed for each packet processing stage in the set of packet processing stages at a particular host computer in the network. The method provides to the packet processing stage a set of trace instructions for use in generating a set of trace data when processing packets belonging to a particular packet flow for which a packet tracing operation has been defined. The method receives from the packet processing stage the set of trace data generated during processing of a packet belonging to the particular packet flow.

Abstract: An example method of beacon probing in a computing system includes: sending, by cross-host beacon probing (CHBP) software executing in a first host of the computing system, a first beacon probe from a first network interface controller (NIC) of the first host to NICs on a same layer 2 domain as the first NIC, the NICs including a second NIC of the first host and cross-host NICs of at least one host other than the first host; receiving, at the CHBP software through the first NIC, acknowledgements (ACKs) to the first beacon probe from the cross-host NICs; and determining, in response to the first beacon probe, connectivity statuses of the first NIC and the second NIC by the CHBP software based on the ACKs and on whether the second NIC receives the first beacon probe.

Abstract: The subject matter described herein provides systems and techniques for the integration of TLVR technology in a vertical power VR module. A multiple-secondary TLVR topology using a controlled leakage inductance in the place of a separate compensation inductor, Lc, may be employed for the vertical power VR module. In addition, the capacitance inside the device to which the TLVR based vertical power VR module supplies power, rather than an output capacitance board, may be used in order to allow the module to be a single layer. Example structures that may include one or more primary windings and/or one or more secondary windings for each of possibly multiple linked phases of the TLVR based module are provided. The windings may be formed using traditional copper windings or printed circuit board (PCB) copper trace winding.

Abstract: The subject matter described herein provides systems and techniques for the integration of TLVR technology in a vertical power VR module. A multiple-secondary TLVR topology using a controlled leakage inductance in the place of a separate compensation inductor, Lc, may be employed for the vertical power VR module. In addition, the capacitance inside the device to which the TLVR based vertical power VR module supplies power, rather than an output capacitance board, may be used in order to allow the module to be a single layer. Example structures that may include one or more primary windings and/or one or more secondary windings for each of possibly multiple linked phases of the TLVR based module are provided. The windings may be formed using traditional copper windings or printed circuit board (PCB) copper trace winding.

Abstract: The subject matter described herein provides systems and techniques for the integration of Trans-Induction Voltage regulator (TLVR) technology in a vertical power Voltage Regulator (VR) module. The capacitance inside the device to which the TLVR based vertical power VR module supplies power, rather than an output capacitance board, may be used in order to allow the module to be a single layer. In some instances, output capacitors may be integrated into components of the structures to provide adequate operational capacitance previously provided by the output capacitance board. Example structures may also include a controller.

Abstract: A test system for measuring the gas permeation parameters of an ultra-low permeability medium in multi-field and multi-phase coupling conditions, comprising a triaxial permeation chamber, a deformation monitoring apparatus, a temperature sensing control apparatus, a volume/pressure controller, a bias stress loading apparatus, a gas injection apparatus, an outlet buffer container, and an ultra-low permeation flow monitoring apparatus. During the test, first applying temperature and triaxial stress control to a rock-soil mass sample; using the gas injection apparatus to inject high-pressure gas into the rock-soil mass sample; after permeation, the high-pressure gas enters the outlet buffer container and the ultra-low permeation flow monitoring apparatus to acquire the gas permeation flow; and, in the test process, the deformation monitoring apparatus can measure the local absolute deformation of the rock-soil mass sample.

Abstract: Provided is a soybean oligosaccharide-related kompetitive allele-specific PCR (KASP) marker and use thereof, belonging to the technical field of molecular breeding. The KASP marker includes one or two of S18_51868868 T/G and S10_38081012 T/C, where the S18_51868868 T/G is a base T or a base G at a 51868868bp position on chromosome 18 of a soybean genome; and the S10_38081012 T/C is a base T or a base C at a 38081012bp position of chromosome 10 of the soybean genome. In the present disclosure, the KASP marker can accurately genotype the traits of raffinose and stachyose contents. Through genotyping, it is found that a soybean germplasm with a genotype GG has a higher raffinose content than that of a soybean germplasm with a genotype TT, and a soybean germplasm with a genotype TT has a higher stachyose content than that of a soybean germplasm with a genotype CC.

Abstract: The present invention relates to a CD16 antibody and the use thereof. Specifically, disclosed are an antibody or an antigen-binding fragment specifically binding CD16, and an encoding nucleic acid, an expression vector and an expression cell thereof, a preparation method therefor, a pharmaceutical composition thereof, and the use thereof for treating diseases, such as the use thereof in the treatment of tumors. The CD16 antibody holds great significance for the development of a CD16 antibody therapeutic drug and a CD16 detection reagent.

Abstract: Disclosed herein are peptides and peptidomimetics that inhibit the progression of prostate cancer by up-regulating FLRT3. Also disclosed are methods for treating an FLRT3-attenuated cancer in a subject that involve administering to the subject the disclosed polypeptide or peptidomimetic or a polynucleotide encoding the disclosed peptide.

Abstract: A cultivation method for drip irrigation of cotton fields in saline-alkali soil is provided, belonging to the field of agricultural planting technologies. It mainly includes performing land preparation; setting a planting mode; laying tubes; performing a high frequency drip irrigation; fertilizing with water; performing intertillage; performing chemical control; and performing green prevention and control.